Cargando…

A raising dawn of pentoxifylline in management of inflammatory disorders in Covid-19

The existing pandemic viral infection caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) leads to coronavirus disease 2019 (Covid-19). SARS-CoV-2 exploits angiotensin-converting enzyme 2 (ACE2) as an entry-point into affected cells and down-regulation of ACE2 by this virus t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mostafa-Hedeab, Gomaa, Al-kuraishy, Hayder M., Al-Gareeb, Ali I., Jeandet, Philippe, Saad, Hebatallah M., Batiha, Gaber El-Saber
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9051499/ https://www.ncbi.nlm.nih.gov/pubmed/35486310 http://dx.doi.org/10.1007/s10787-022-00993-1

Ejemplares similares

Roxadustat for SARS-CoV-2 Infection: Old Signaling Raised New Hopes
por: Alkazmi, Luay, et al.
Publicado: (2022)

COVID-19 and corticosteroids: a narrative review
por: El-Saber Batiha, Gaber, et al.
Publicado: (2022)

The effect of ramatroban on cytokine and thrombotic storms in Covid-19
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2022)

Hippo-YAP signaling and SARS-CoV-2 infection: a new mechanistic pathway
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2023)

Selinexor and COVID-19: The Neglected Warden
por: Mostafa-Hedeab, Gomaa, et al.
Publicado: (2022)

Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

New insights on the potential effect of progesterone in Covid‐19: Anti‐inflammatory and immunosuppressive effects
por: Al‐Kuraishy, Hayder M., et al.
Publicado: (2023)

Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

The potential role of scavenger receptor B type I (SR‐BI) in SARS‐CoV‐2 infection
por: Alkazmi, Luay, et al.
Publicado: (2023)

The potential role of human islet amyloid polypeptide in type 2 diabetes mellitus and Alzheimer’s diseases
por: Alrouji, Mohammed, et al.
Publicado: (2023)

The possible role of ursolic acid in Covid-19: A real game changer
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

Synergistic effect of berberine and pentoxifylline in attenuation of acute kidney injury
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2019)

NF‐κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective
por: Alrouji, Mohammed, et al.
Publicado: (2023)

COVID-19 and Risk of Acute Ischemic Stroke and Acute Lung Injury in Patients With Type II Diabetes Mellitus: The Anti-inflammatory Role of Metformin
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

The crucial role of prolactin-lactogenic hormone in Covid-19
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2022)

COVID-19 and erythrocrine function: The roller coaster and danger
por: Al-kuraishy, Hayder M, et al.
Publicado: (2022)

Dipyridamole and adenosinergic pathway in Covid-19: a juice or holy grail
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

Nitazoxanide and COVID-19: A review
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

Potential role of lipoxin in the management of COVID-19: a narrative review
por: Batiha, Gaber El-Saber, et al.
Publicado: (2022)

SIRT1 pathway in Parkinson’s disease: a faraway snapshot but so close
por: Batiha, Gaber El-Saber, et al.
Publicado: (2022)

The Potential Role of Growth Differentiation Factor 15 in COVID-19: A Corollary Subjective Effect or Not?
por: Babalghith, Ahmad O., et al.
Publicado: (2022)

Plasminogen activator inhibitor 1 and gestational diabetes: the causal relationship
por: Batiha, Gaber El-Saber, et al.
Publicado: (2022)

Vinpocetine is the forthcoming adjuvant agent in the management of COVID-19
por: Al-kuraishy, Hayder M, et al.
Publicado: (2022)

Trimetazidine and COVID-19-induced acute cardiac injury: a missed key
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

Pathophysiology of Post-COVID syndromes: a new perspective
por: Batiha, Gaber El-Saber, et al.
Publicado: (2022)

Statins Use in Alzheimer Disease: Bane or Boon from Frantic Search and Narrative Review
por: Alsubaie, Nawal, et al.
Publicado: (2022)

Pros and cons for statins use and risk of Parkinson's disease: An updated perspective
por: Al‐kuraishy, Hayder M., et al.
Publicado: (2023)

The potential role of SARS‐CoV‐2 infection in acute coronary syndrome and type 2 myocardial infarction (T2MI): Intertwining spread
por: Alsaidan, Aseel Awad, et al.
Publicado: (2023)

Autophagy and autophagy signaling in Epilepsy: possible role of autophagy activator
por: Ali, Naif H., et al.
Publicado: (2023)

New insights on the potential effect of vinpocetine in Parkinson’s disease: one of the neglected warden and baffling topics
por: Al-kuraishy, Hayder M., et al.
Publicado: (2023)

Insights on Covid‐19 with superimposed pulmonary histoplasmosis: The possible nexus
por: Almutawif, Yahya A., et al.
Publicado: (2023)

Testosterone in COVID-19: An Adversary Bane or Comrade Boon
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

Hemolytic anemia in COVID-19
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

Metformin and growth differentiation factor 15 (GDF15) in type 2 diabetes mellitus: A hidden treasure
por: Al‐kuraishy, Hayder M., et al.
Publicado: (2022)

Montelukast and Acute Coronary Syndrome: The Endowed Drug
por: Alomair, Basil Mohammed, et al.
Publicado: (2022)

Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal
por: Batiha, Gaber El-Saber, et al.
Publicado: (2022)

Combination of Panax ginseng C. A. Mey and Febuxostat Boasted Cardioprotective Effects Against Doxorubicin-Induced Acute Cardiotoxicity in Rats
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2022)

Sequential doxycycline and colchicine combination therapy in Covid-19: The salutary effects
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

Niclosamide for Covid-19: bridging the gap
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons
por: Al-kuraishy, Hayder M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ookpjs3gmg44o29egd4dbcbo0s